Kazumasa Miki Selected Research

von Willebrand Factor

9/2009	Significance of lymphatic invasion and cancer invasion-related proteins on lymph node metastasis in gastric cancer.
2/2009	Histopathological predictor for regional lymph node metastasis in gastric cancer.
1/2007	Significance of lymphatic invasion on regional lymph node metastasis in early gastric cancer using LYVE-1 immunohistochemical analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazumasa Miki Research Topics

Disease

10	Neoplasms (Cancer) 01/2017 - 08/2002
10	Stomach Neoplasms (Stomach Cancer) 06/2012 - 01/2003
6	Infections 01/2017 - 02/2002
6	Atrophic Gastritis 01/2011 - 04/2003
4	Adenocarcinoma 06/2012 - 08/2002
3	Metaplasia 01/2011 - 05/2004
3	Lymphatic Metastasis 09/2009 - 01/2007
3	Liver Cirrhosis (Hepatic Cirrhosis) 11/2008 - 01/2007
3	Hepatocellular Carcinoma (Hepatoma) 11/2008 - 01/2007
2	Gastritis 01/2011 - 01/2003
2	Gastroesophageal Reflux (GERD) 09/2008 - 05/2006
1	Hypersensitivity (Allergy) 01/2017
1	Atrophy 11/2010
1	Neoplasms, Cystic, Mucinous, and Serous 04/2010
1	Hyperplasia 04/2010
1	Neoplasm Metastasis (Metastasis) 09/2009
1	Abscess 03/2009
1	Intestinal Volvulus (Volvulus) 09/2008
1	Fibrosis (Cirrhosis) 07/2008
1	Inflammation (Inflammations) 02/2007
1	Insulin Resistance 05/2006
1	Chronic Hepatitis C 01/2006
1	Ulcerative Colitis 08/2005
1	Adenoma (Adenomas) 08/2002

Drug/Important Bio-Agent (IBA)

11	Pepsinogen A (Pepsinogen)IBA 01/2011 - 02/2002
5	AntibodiesIBA 11/2010 - 07/2004
4	HydrogenIBA 09/2008 - 05/2006
3	Hyaluronic Acid (Hyaluronan)IBA 09/2009 - 01/2007
3	von Willebrand FactorIBA 09/2009 - 01/2007
2	Immunoglobulin G (IgG)IBA 01/2011 - 07/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2008 - 08/2002
2	CarbohydratesIBA 05/2006 - 05/2006
1	Penicillins (Penicillin)FDA Link 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 06/2012
1	MucinsIBA 04/2010
1	Claudin-4IBA 09/2009
1	Proteins (Proteins, Gene)FDA Link 09/2009
1	Matrix Metalloproteinases (MMPs)IBA 09/2009
1	beta CateninIBA 09/2009
1	ClaudinsIBA 09/2009
1	Claudin-3IBA 09/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2009
1	Indicators and Reagents (Reagents)IBA 02/2009
1	Vascular Endothelial Growth Factor CIBA 02/2009
1	Immune Sera (Antisera)IBA 02/2009
1	TNF-Related Apoptosis-Inducing LigandIBA 07/2008
1	CytokinesIBA 07/2008
1	Biomarkers (Surrogate Marker)IBA 02/2007
1	Fluorouracil (Carac)FDA LinkGeneric 01/2007
1	Leucovorin (Folinic Acid)FDA Link 01/2007
1	Cisplatin (Platino)FDA LinkGeneric 01/2007
1	Glucose (Dextrose)FDA LinkGeneric 05/2006
1	InterferonsIBA 01/2006
1	Ribavirin (Virazole)FDA LinkGeneric 01/2006
1	BariumIBA 10/2005
1	Immunoglobulin A (IgA)IBA 07/2004
1	Methylene Blue (Methylthioninium Chloride)FDA Link 07/2004
1	Coloring Agents (Dyes)IBA 07/2004
1	PepsinogensIBA 05/2004
1	Pepsinogen CIBA 01/2003
1	alpha E integrinsIBA 08/2002
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 08/2002
1	invariant chain (Ii-Key)IBA 08/2002
1	Methylnitronitrosoguanidine (MNNG)IBA 08/2002

Therapy/Procedure

2	Therapeutics 01/2017 - 01/2007
2	Drug Therapy (Chemotherapy) 11/2008 - 07/2008
1	Gastric Balloon 09/2008
1	Combination Drug Therapy (Combination Chemotherapy) 07/2008
1	Gastrectomy 09/2007
1	Intra-Arterial Infusions 01/2007
1	Kidney Transplantation 08/2005